Nano cap Cocrystal Pharma (NASDAQ:COCP) jumps 36% after hours on the heels of its announcement that it has initiated a coronavirus program.
Last week, it announced a
license deal with Kansas State University Research Foundation (KSURF)
for certain antiviral compounds for the potential treatment of norovirus
and coronavirus infections.
It says that it will seek collaboration partners to advance development.
https://seekingalpha.com/news/3549508-cocrystal-pharma-up-36-after-hours-on-launch-of-coronavirus-program
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.